Gliknik is a leading biopharmaceutical company that is dedicated to improving the lives of individuals with immune disorders. With a strong focus on scientific expertise and extensive experience in the biopharmaceutical industry, the Gliknik team is committed to developing new therapies to alleviate human suffering. Currently, Gliknik is at the forefront of medical innovation with two groundbreaking drugs undergoing clinical trials, while also actively advancing other promising candidates at the preclinical stage.

Their team's shared dedication is to always make the right choices and strive for excellence in their work. Driven by their unwavering mission to apply cutting-edge science in order to improve the lives of those with immune disorders, Gliknik is dedicated to discovering and developing truly innovative biologics. With a strong emphasis on research, development, and the pursuit of groundbreaking treatments, Gliknik is a trailblazer in the field of biopharmaceuticals, offering hope and relief to those in need